Your browser doesn't support javascript.
loading
Exhaled and nasal nitric oxide in chronic rhinosinusitis patients with nasal polyps in primary care.
Frendø, M; Håkansson, K; Schwer, S; Ravn, A T; Meteran, H; Porsbjerg, C; Backer, V; von Buchwald, C.
Affiliation
  • Frendø M; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Håkansson K; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Schwer S; Susanne Schwer ear, nose and throat clinic, Valby, Copenhagen, Denmark.
  • Ravn AT; Frederiksberg ear, nose and throat clinic, Frederiksberg, Copenhagen Denmark.
  • Meteran H; Department of Respiratory Medicine L, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
  • Porsbjerg C; Department of Respiratory Medicine L, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
  • Backer V; Department of Respiratory Medicine L, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
  • von Buchwald C; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
Rhinology ; 56(1): 59-64, 2018 03 01.
Article in En | MEDLINE | ID: mdl-29166423
ABSTRACT

BACKGROUND:

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disorder associated with lower airway disease. However, only few studies of CRSwNP from outside secondary/tertiary care centres have been published. We recently reported an asthma frequency of 44% and 65% in primary and secondary care patients respectively. Therefore, we hypothesise that inflammation of the lower airways could be present in all CRSwNP patients, even without asthma. Here, we assessed the degree of lower and upper airway inflammation using exhaled and nasal nitric oxide (NO) in primary care CRSwNP patients with and without asthma.

METHODS:

Fifty-seven patients who met the EPOS criteria for CRSwNP were prospectively recruited from primary care ear, nose and throat clinics. Nasal endoscopy was performed by an ear, nose and throat specialist upon enrolment. Additionally, 30 healthy controls were enrolled. Expiratory and nasal NO measurements and thorough pulmonary evaluation were performed. Pulmonary disease was diagnosed by a respiratory physician.

RESULTS:

Fifty-nine percent of CRSwNP patients with asthma showed elevated expiratory NO; the same was seen in 29% of non-asthmatic CRSwNP patients. Compared with controls, a high level of exhaled NO was significantly more prevalent in CRSwNP irrespective of asthma-status. Nasal NO was significantly lower in patients with CRSwNP compared with controls.

CONCLUSION:

Subclinical eosinophilic lower airway inflammation is common in CRSwNP in the primary sector, even in the absence of asthma.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sinusitis / Rhinitis / Nasal Polyps / Nitric Oxide Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Rhinology Year: 2018 Document type: Article Affiliation country: Dinamarca

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sinusitis / Rhinitis / Nasal Polyps / Nitric Oxide Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Rhinology Year: 2018 Document type: Article Affiliation country: Dinamarca